Mesothelin-Targeted Immunotoxin LMB-100 in People With Malignant Mesothelioma
Clinical trial NCT02798536 · COMPLETED
Trial details
- NCT number
- NCT02798536
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-27
- Primary completion
- 2017-07-20
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.